{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:12:26Z","timestamp":1791893546655,"version":"4.3.4"},"reference-count":105,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.beem.2025.101986","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T21:23:11Z","timestamp":1741468991000},"page":"101986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Persistence and Recurrence of Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"39","author":[{"given":"Rasha A.Y.","family":"Alnajmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Min Res"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4158\/EP.3.1.22","article-title":"Primary hyperparathyroidism: diagnosis and management","volume":"3","author":"Khan","year":"1997","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2025.101986_bib4","series-title":"Endotext","article-title":"Primary Hyperparathyroidism","author":"Walker","year":"2000"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2025.101986_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.beem.2018.09.004","article-title":"Primary hyperparathyroidism","volume":"32","author":"Silva","year":"2018","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib7","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/jbmr.4685","article-title":"The efficacy and safety of medical and surgical therapy in patients with primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Ye","year":"2022","journal-title":"J Bone Min Res"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib8","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.101986_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03345354","article-title":"Risk factors associated to kidney stones in primary hyperparathyroidism","volume":"28","author":"Corbetta","year":"2005","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"10.1016\/j.beem.2025.101986_bib10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40618-019-01107-5","article-title":"Whole exome sequencing in familial isolated primary hyperparathyroidism","volume":"43","author":"Cetani","year":"2020","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib12","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jc.2015-3964","article-title":"Thiazide-associated hypercalcemia: incidence and association with primary hyperparathyroidism over two decades","volume":"101","author":"Griebeler","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2020.0457","article-title":"Lithium-associated hyperparathyroidism","volume":"81","author":"Mifsud","year":"2020","journal-title":"Br J Hosp Med"},{"issue":"9","key":"10.1016\/j.beem.2025.101986_bib14","article-title":"A case of lithium-associated hypocalciuric hypercalcemia","volume":"12","author":"Nwabufor","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib15","first-page":"184","article-title":"Primary hyperparathyroidism: pathophysiology and impact on bone","volume":"163","author":"Khan","year":"2000","journal-title":"Can Med Assoc J"},{"issue":"5","key":"10.1016\/j.beem.2025.101986_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4158\/EP.6.5.385","article-title":"Skeletal effects of primary hyperparathyroidism","volume":"6","author":"Syed","year":"2000","journal-title":"Endocr Pr: J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib17","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jbmr.4679","article-title":"Classical and nonclassical manifestations of primary hyperparathyroidism","volume":"37","author":"El-Hajj Fuleihan","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.beem.2025.101986_bib18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/000313481608200948","article-title":"Neuropsychological changes in primary hyperparathyroidism after parathyroidectomy","volume":"82","author":"Liu","year":"2016","journal-title":"Am Surg"},{"issue":"7","key":"10.1016\/j.beem.2025.101986_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2017.16111226","article-title":"Psychiatric complications of primary hyperparathyroidism and mild hypercalcemia","volume":"174","author":"Parks","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.surg.2020.06.006","article-title":"Neuropsychologic changes in primary hyperparathyroidism after parathyroidectomy from a dual-institution prospective study","volume":"169","author":"Liu","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2025.101986_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/408295","article-title":"Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results","volume":"2012","author":"Luigi","year":"2012","journal-title":"Int J Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2025.101986_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism","volume":"31","author":"Walker","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5005\/jp-journals-10002-1209","article-title":"Assessment of cardiovascular system abnormalities in patients with advanced primary hyperparathyroidism by detailed echocardiographic analysis: a prospective study","volume":"9","author":"Mishra","year":"2017","journal-title":"World J Endocr Surg"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/jbmr.090728","article-title":"Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients","volume":"25","author":"Priemel","year":"2010","journal-title":"J Bone Min Res"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamainternmed.2014.5857","article-title":"Association of loop diuretic use with higher parathyroid hormone levels in patients with normal renal function","volume":"175","author":"Corapi","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.beem.2025.101986_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.beem.2025.101986_bib27","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101986_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fcell.2020.00399","article-title":"Paget's disease and secondary hyperparathyroidism: is healing possible?","volume":"8","author":"Panuccio","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"10.1016\/j.beem.2025.101986_bib29","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/jcm10081604","article-title":"Primary hyperparathyroidism: a narrative review of diagnosis and medical management","volume":"10","author":"Dandurand","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.beem.2013.04.007","article-title":"Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism","volume":"27","author":"Hannan","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1151","key":"10.1016\/j.beem.2025.101986_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/postgradmedj-2020-137718","article-title":"Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best?","volume":"97","author":"Arshad","year":"2021","journal-title":"Post Med J"},{"issue":"9","key":"10.1016\/j.beem.2025.101986_bib32","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s00268-014-2517-z","article-title":"Primary hyperparathyroidism: an analysis of failure of parathyroidectomy","volume":"38","author":"Agrawal","year":"2014","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.surg.2021.09.018","article-title":"How and when is multiglandular disease diagnosed in sporadic primary hyperparathyroidism?","volume":"171","author":"Shah","year":"2022","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","article-title":"A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism","volume":"19","author":"Cheung","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.beem.2025.101986_bib35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jamaoto.2018.1671","article-title":"Preoperative imaging techniques in primary hyperparathyroidism: a review","volume":"144","author":"Bunch","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"12","key":"10.1016\/j.beem.2025.101986_bib36","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1097\/01.mlg.0000149451.45264.90","article-title":"Preoperative ultrasound is worthwhile for reoperative parathyroid surgery","volume":"114","author":"Ghaheri","year":"2004","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib37","first-page":"7","article-title":"Preoperative localization studies in primary hyperparathyroidism","volume":"53","author":"Uludag","year":"2019","journal-title":"Sisli Etfal Hast Tip Bul"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2967\/jnmt.112.105122","article-title":"SNM practice guideline for parathyroid scintigraphy 4.0","volume":"40","author":"Greenspan","year":"2012","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.beem.2025.101986_bib39","first-page":"123","article-title":"Update of the role of Nuclear Medicine techniques in the pre-surgical localization of primary hyperparathyroidism","volume":"38","author":"Garc\u00eda-Talavera San Miguel","year":"2019"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiology.214.2.r00fe04393","article-title":"Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules","volume":"214","author":"De Feo","year":"2000","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib41","article-title":"Fluorine-18 fluorocholine positron emission tomography\/computed tomography in primary hyperparathyroidism: a case report and review of literature","volume":"14","author":"Ramalho","year":"2022","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.beem.2025.101986_bib42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12149-020-01507-1","article-title":"18)F-choline PET\/CT and PET\/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature","volume":"34","author":"Evangelista","year":"2020","journal-title":"Ann Nucl Med"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib43","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.ejrad.2012.05.023","article-title":"Dynamic magnetic resonance angiography for localization of hyperfunctioning parathyroid glands in the reoperative neck","volume":"81","author":"Aschenbach","year":"2012","journal-title":"Eur J Radio"},{"issue":"5","key":"10.1016\/j.beem.2025.101986_bib44","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jamcollsurg.2007.12.044","article-title":"Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography","volume":"206","author":"Mortenson","year":"2008","journal-title":"J Am Coll Surg"},{"issue":"10","key":"10.1016\/j.beem.2025.101986_bib45","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.sla.0000179622.37270.36","article-title":"A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?","volume":"242","author":"Chen","year":"2005","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.beem.2025.101986_bib47","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.surg.2008.06.017","article-title":"Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach","volume":"144","author":"Yen","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2025.101986_bib48","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.12659\/MSM.890983","article-title":"Reoperations for persistent or recurrent primary hyperparathyroidism: results of a retrospective cohort study at a tertiary referral center","volume":"20","author":"Nawrot","year":"2014","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.beem.2025.101986_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3803\/EnM.2019.34.4.327","article-title":"Intraoperative Parathyroid Hormone Monitoring in the Surgical Management of Sporadic Primary Hyperparathyroidism.","volume":"34","author":"Khan","year":"2019","journal-title":"Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib50","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/jbmr.4689","article-title":"Surgical Aspects of Primary Hyperparathyroidism","volume":"37","author":"Perrier","year":"2022","journal-title":"J Bone Min Res"},{"issue":"10","key":"10.1016\/j.beem.2025.101986_bib51","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/ndt\/14.10.2398","article-title":"The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism","volume":"14","author":"Malberti","year":"1999","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"10.1016\/j.beem.2025.101986_bib52","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1245\/s10434-016-5190-7","article-title":"Delayed calcium normalization after presumed curative parathyroidectomy is not associated with the development of persistent or recurrent primary hyperparathyroidism","volume":"23","author":"Lai","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2025.101986_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2024.115826","article-title":"Persistent and recurrent hyperparathyroidism - attitude","author":"Procopio","year":"2024","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.beem.2025.101986_bib54","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-197610000-00001","article-title":"Recurrent hyperparathyroidism","volume":"184","author":"Clark","year":"1976","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib55","first-page":"1","article-title":"A. Persistent and recurrent primary hyperparathyroidism: etiological factors and pre-operative evaluation","volume":"57","author":"Unlu","year":"2023","journal-title":"Sisli Etfal Hast Tip Bul"},{"issue":"8","key":"10.1016\/j.beem.2025.101986_bib56","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/hed.25023","article-title":"AHNS series: do you know your guidelines? optimizing outcomes in reoperative parathyroid surgery: definitive multidisciplinary joint consensus guidelines of the american head and neck society and the british association of endocrine and thyroid surgeons","volume":"40","author":"Stack","year":"2018","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s13304-017-0447-7","article-title":"Persistent and recurrent hyperparathyroidism","volume":"69","author":"Guerin","year":"2017","journal-title":"Updates Surg"},{"issue":"9","key":"10.1016\/j.beem.2025.101986_bib58","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ciresp.2021.06.005","article-title":"Risk factors for surgical failure in patients undergoing surgery for primary hyperparathyroidism","volume":"100","author":"Olgu\u00edn Joseau","year":"2022","journal-title":"Cir Esp (Engl Ed"},{"issue":"4","key":"10.1016\/j.beem.2025.101986_bib59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/SLA.0b013e3181f698df","article-title":"Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume","volume":"252","author":"Chen","year":"2010","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.beem.2025.101986_bib60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00423-019-01782-1","article-title":"Mild sporadic primary hyperparathyroidism: high rate of multiglandular disease is associated with lower surgical cure rate","volume":"404","author":"Tr\u00e9bouet","year":"2019","journal-title":"Lange Arch Surg"},{"key":"10.1016\/j.beem.2025.101986_bib61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jss.2019.08.007","article-title":"Persistent\/recurrent primary hyperparathyroidism: does the number of abnormal glands play a role?","volume":"246","author":"Mazotas","year":"2020","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11864-011-0171-3","article-title":"Parathyroid carcinoma: update and guidelines for management","volume":"13","author":"Wei","year":"2012","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib63","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s002680010220","article-title":"Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism","volume":"24","author":"Pattou","year":"2000","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12902-019-0346-7","article-title":"Recurrent tertiary hyperparathyroidism due to supernumerary parathyroid glands in a patient receiving long-term hemodialysis: a case report","volume":"19","author":"Tai","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0104-4230(12)70202-6","article-title":"Supernumerary parathyroid glands in hyperparathyroidism associated with multiple endocrine neoplasia type 1","volume":"58","author":"d'Alessandro","year":"2012","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.beem.2025.101986_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.6061\/clinics\/2012(Sup01)23","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?","volume":"67","author":"Giusti","year":"2012","journal-title":"Clinics"},{"issue":"6","key":"10.1016\/j.beem.2025.101986_bib67","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.4158\/ACCR-2019-0225","article-title":"PArathyromatosis: a rare case of recurrent hyperparathyroidism localized by four-dimensional computed tomography","volume":"5","author":"Wei","year":"2019","journal-title":"AACE Clin Case Rep"},{"issue":"6","key":"10.1016\/j.beem.2025.101986_bib68","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.metabol.2011.11.001","article-title":"Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism","volume":"61","author":"Hage","year":"2012","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib69","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jss.2014.02.024","article-title":"Recurrent and persistence primary hyperparathyroidism occurs more frequently in patients with double adenomas","volume":"190","author":"Alhefdhi","year":"2014","journal-title":"J Surg Res"},{"issue":"8","key":"10.1016\/j.beem.2025.101986_bib70","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archsurg.136.8.878","article-title":"OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma","volume":"136","author":"Arici","year":"2001","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.beem.2025.101986_bib71","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1308\/rcsann.2019.0105","article-title":"Parathyromatosis: a very rare cause of recurrent primary hyperparathyroidism - case report and review of the literature","volume":"101","author":"Haciyanli","year":"2019","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.beem.2025.101986_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00618","article-title":"Intraoperative decision-making and technical aspects of parathyroidectomy in young patients with MEN1 related hyperparathyroidism","volume":"9","author":"Nobecourt","year":"2018","journal-title":"Front Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2025.101986_bib73","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib74","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.surg.2016.06.065","article-title":"Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism","volume":"161","author":"Silva","year":"2017","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.beem.2025.101986_bib75","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth International workshop on the management of asymptomatic primary hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.101986_bib76","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.beem.2025.101986_bib77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2265.2007.03109.x","article-title":"Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism","volume":"68","author":"Moosgaard","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib78","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bone.2010.10.004","article-title":"Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism","volume":"48","author":"Stein","year":"2011","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.beem.2025.101986_bib79","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cen.12398","article-title":"Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature","volume":"80","author":"Shah","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib80","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib81","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Min Res"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib82","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4158\/EP10202.OR","article-title":"Vitamin D status and its relationship with bone mineral density and parathyroid hormone in Southeast Asian adults with low bone density","volume":"17","author":"Chandran","year":"2011","journal-title":"Endocr Pr"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib83","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1210\/jc.2013-3523","article-title":"Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism","volume":"99","author":"Walker","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib84","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.beem.2025.101986_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-024-01075-8","article-title":"Hypoparathyroidism: diagnosis, management and emerging therapies","author":"Khan","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2025.101986_bib86","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2025.101986_bib87","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2025.101986_bib88","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-14-0877","article-title":"Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery","volume":"172","author":"Khan","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib89","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11154-021-09694-6","article-title":"The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies","volume":"23","author":"Chandran","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2025.101986_bib90","series-title":"Basic Medical Endocrinology","first-page":"197","author":"Goodman","year":"2009"},{"key":"10.1016\/j.beem.2025.101986_bib91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases","volume":"15","author":"Hannan","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2025.101986_bib92","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2025.101986_bib93","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4158\/EP08178.ORR","article-title":"Alendronate therapy in men with primary hyperparathyroidism","volume":"15","author":"Khan","year":"2009","journal-title":"Endocr Pr"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib94","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00774-013-0473-6","article-title":"Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism","volume":"32","author":"Tournis","year":"2014","journal-title":"J Bone Min Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib95","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2265.1990.tb00869.x","article-title":"Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status","volume":"32","author":"Schmidli","year":"1990","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.101986_bib96","first-page":"132","article-title":"[Primary hyperparathyroidism. An alternative to the surgery]","volume":"56","author":"D\u00edaz Guardiola","year":"2009"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib97","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jgs.15250","article-title":"Protective effect of denosumab on bone in older women with primary hyperparathyroidism","volume":"66","author":"Eller-Vainicher","year":"2018","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.1016\/j.beem.2025.101986_bib98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S2213-8587(20)30063-2","article-title":"Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Leere","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib99","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s12020-020-02401-6","article-title":"Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism","volume":"69","author":"Miyaoka","year":"2020","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.beem.2025.101986_bib100","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12020-023-03381-z","article-title":"Denosumab for osteoporosis in patients with primary hyperparathyroidism and mild-to-moderate renal insufficiency","volume":"81","author":"Gronskaya","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2025.101986_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1098841","article-title":"Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: a systematic review and meta-analysis","volume":"14","author":"Rajput","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib102","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-011-9459-0","article-title":"Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism","volume":"39","author":"Faggiano","year":"2011","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.beem.2025.101986_bib103","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.beem.2025.101986_bib104","first-page":"1076","article-title":"Comparison of alendronate and raloxifene for the management of primary hyperparathyroidism","volume":"36","author":"Akbaba","year":"2013","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.beem.2025.101986_bib105","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T09:33:16Z","timestamp":1741858396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X25000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1521690X25000193"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.101986","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence and Recurrence of Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.101986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101986"}}